References
- Agol V.I. 2006. Molecular mechanisms of poliovirus variation and evolution. Curr. Top. Microbiol. 299: 211–259.
- Balanant J., S. Guillot, A. Candrea, F. Delpeyroux and R. Crainic. 1991. The natural genomic variability of poliovirus analyzed by a restriction fragment length polymorphism assay. Virology 184: 645–654.
- Blomqvist S., A.L. Bruu, M. Stenvik and T. Hovi. 2003. Characterization of a recombinant type 3/type 2 poliovirus isolated from a healthy vaccine and containing a chimeric capsid protein VP1. J. Gen. Virol. 84: 573–580.
- Bouchard M.J., D.H. Lam and V.R. Racaniello. 1995. Determinants of attenuation and temperature sensitivity in the type 1 poliovirus Sabin vaccine. J. Virol. 69: 4972.
- CDC. 2007. Laboratory surveillance for wild and vaccine-derived polioviruses-worldwide, January 2006-June 2007. Morb. Mortal. Wkly. Rep. 56: 965–969.
- Cernáková B., Z. Sobotová, I. Rovný, S. Bláhova, M. Roivainen and T. Hovi. 2005. Isolation of vaccine-derived polioviruses in the Slovak Republic. Eur. J. Clin. Microbiol. Infect. Dis. 24: 438–439.
- Dedepsidis E., Z. Kyriakopoulou, V. Pliaka, C. Kottaridi, E. Bolanaki, S. Levidiotou-Stefanou, D. Komiotis and P. Markoulatos. 2007. Retrospective Characterization of a Vaccine-Derived Poliovirus Type 1 Isolate from Sewage in Greece. Appl. Environ. Microbiol. 73: 6697–6704.
- Dowdle W.R., H.G. Gary, R. Sanders and A.N. van Loon. 2006. Containment of polioviruses after eradication and OPV cessation: characterizing risks to improve management. Risk Anal. 26: 1449–1469.
- Furione M., S. Guillot, D. Otelea, J. Balanant, A. Candrea and R. Crainic. 1993. Polioviruses with natural genomes isolates from vaccine-associated paralytic poliomyelitis. Virology 196: 199–208.
- Hamza I.A., L. Jurzik, K. Uberla and M. Wilhelm. 2011. Methods to detect infectious human enteric viruses in environmental water samples. Int. J. Hyg. and Environ. Health 214: 424–436.
- Hovi T., L.M. Shulman, H. van der Avoort, J. Deshpande, M. Roivainen and E.M. de Gourville. 2010. Role of environmental poliovirus surveillance in global polio eradication and beyond. Epidemiol. Infect. 140: 1–13.
- Kew O.M. and B.K. Nottay. 1984. Evolution of the oral poliovaccine strains in humans occurs by both mutation and intramolecular recombination. In R. Chanock and R. Lerner (Ed.), Modern approaches to vaccines (pp. 357–367). New York: Cold Spring Harbor.
- Kew O.M., R.W. Sutter, E.M. de Gourville, W.R. Dowdle and M.A. Pallansch. 2005. Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Annu. Rev. Microbiol. 59: 587–635.
- Klement C., R. Kissova, V. Lengyelova, D. Stipalova, Z. Sobotova, J.M. Galama and S. Bopegamage. 2013. Human enterovirus surveillance in the Slovak Republic from 2001–2011. Epidemiol. Infect. 141: 2658–2662.
- Landsteiner K. and E. Popper. 1909. Transmission of poliomyelitis on monkeys (Ubertragung der Poliomyelitis acuta auf Affen). Z. Immunitatstorsch. Orig. 2: 377–390.
- Macadam A.J., C. Arnold, J. Howlett, A. John, S. Marsden, F. Taffs, P. Reeve, N. Hamada, K. Wareham and J. Almond. 1989. Reversion of the attenuated and temperature-sensitive phenotypes of the Sabin type 3 strain of poliovirus in vaccines. Virology 172: 408–414.
- Macadam A.J., S.R. Pollard, G. Ferguson, R. Skuce, D. Wood, J.W. Almond and P.D. Minor. 1993. Genetic basis of attenuation of the Sabin type 2 vaccine strain of poliovirus in primates. Virology 192: 18–26.
- Manor Y., R. Handsher, T. Halmut, M. Neuman, A. Bobrov, H. Rudich, A. Vonsover, L. Shulman, O. Kew and E. Mendelson. 1999. Detection of poliovirus circulation by environmental surveillance in the absence of clinical cases in Israel and the Palestinian authority. J. Clin. Microbiol. 37: 1670–1675.
- Manor Y., S. Blomqvist, D. Sofer, J. Alfandari, T. Halmut, B. Abramovitz, E. Mendelson and L.M. Shulman. 2007. Advanced environmental surveillance and molecular analyses indicate separate importations rather than endemic circulation of wild type 1 poliovirus in Gaza district in 2002. Appl. Environ. Microbiol. 73: 5954–5958.
- Minor P.D. 2004. Polio eradication, cessation of vaccination and re-emergence of disease. Nat. Rev. Microbiol. 2: 473–482.
- Mueller J.E., M. Bessaud, Q.S. Huang, L.C. Martinez, P.A. Barril, V. Morel, J. Balanant, J. Bocacao, J. Hewitt, B.D. Gessner, F. Delpeyroux and S.V. Nates. 2009. Environmental poliovirus surveillance during oral poliovirus vaccine and inactivated poliovirus vaccine use in Córdoba Province, Argentina. Appl. Environ. Microbiol. 75: 1395–1401.
- Nakamura T., M. Hamasaki, H. Yoshitomi, T. Ishibashi, C. Yoshiyama, E. Maeda, N. Sera, and H. Yoshida. 2015. Environmental surveillance of poliovirus in sewage water around the introduction period for inactivated polio vaccine in Japan. Appl. Environ. Microbiol. 81: 1859–1864.
- Pinto R.M., R. Gajardo, F.X. Abad and A. Bosch. 1995. Detection of fastidious infectious enteric viruses in water. Environ. Sci. Technol. 29: 2636–2638.
- Ren R.B., E.G. Moss and V.R. Racaniello. 1991. Identification of two determinants that attenuate vaccine-related type 2 poliovirus. J. Virol. 65: 1377–1382.
- Roivainen M., S. Blomqvist H. Al-Hello, A. Paananen, F. Delpeyroux, M. Kuusi and T. Hovi. 2010. Highly divergent neurovirulent vaccine-derived polioviruses of all three serotypes are recurrently detected in Finnish sewage. Eur. Surveill. 15: pii/19566.
- Sabin A.B. 1956. Pathogenesis of poliomyelitis. Reappraisal in the light of new data. Science 123: 1151–1157.
- Sabin A.B. and L.R. Boulger. 1973. History of Sabin attenuated poliovirus oral live vaccine strains. J. Biol. Stand. 1: 115–118.
- Sarijlou M., M. Kargar, H. Tabatabaei, M. Ghodsi, R. Nategh and S. Sadeghi. 2007. Poliovirus environmental surveillance in sewage system of Tehran: isolation and identification of viruses by cell culture and microneutralization, and intratypic differentiation by ELISA and probe hybridization. Hakim Res. J. 10: 43–49.
- Stanway G., P.J. Hughes, R.C. Mountford, P. Reeves, P.D. Minor, G.C. Schild and J.W. Almond. 1984. Comparison of the complete nucleotide sequence of the genomes of the neurovirulent poliovirus P3/Leon/37 and its attenuated Sabin vaccine derivative P3/Leon/12. Proc. Natl. Acad. Sci. 81: 1539–1543.
- Wahjuhono G., D. Widhiastuti, J. Sundoro, T. Mardani, W.U. Ratih, R. Sutomo, I. Safitri, O.D. Sampurno, B. Rana, M. Roivainen, A.L. Kahn, O. Mach, M.A. Pallansch and R.W. Sutter. 2014. Switch from oral to inactivated poliovirus vaccine in Yogyakarta Province, Indonesia: summary of coverage, immunity, and environmental surveillance. J. Infect. Dis. 210: 347–352.
- Westrop G.D., K.A. Wareham, D.M. Evans, G. Dunn, P.D. Minor, D.I. Magrath, F. Taffs, S. Marsden, M.A. Skinner, G.C. Schild and J.W. Almond. 1989. Genetic basis of attenuation of Sabin type 3 oral poliovirus vaccine. J. Virol. 63: 1338–1344.
- WHO. 2003. Guidelines for environmental surveillance of poliovirus circulation.
- WHO. 2004. Polio laboratory manual. 4th edition.
- Wieczorek M., Ł. Kuryk, A. Witek, A. Diuwe and B. Litwińska. 2013. Detection of enteroviruses in sewage using Caco-2 Cells. Pol. J. Microbiol. 62: 97–100.
- Yoshida H., H. Horie, K. Matsuura and T. Miyamura. 2000. Characterisation of vaccine-derived polioviruses isolated from sewage and river water in Japan. Lancet 356: 1461–1463.
- Zurbriggen S., K. Tobler, C. Abril, S. Diedrich, M. Ackermann, M.A. Pallansch and A. Metzler. 2008. Isolation of sabin-like polioviruses from wastewater in a country using inactivated polio vaccine. Appl. Environ. Microbiol. 74: 5608–5614.